脾虚肝郁型IBS-D患者应用参苓白术散联合氟哌噻吨美利曲辛片的临床观察

摘要

Objective To investigate clinical effect of shenlingbaizhu powder combined with flupentixol and melitracen tablets in treatment of spleen deficiency and liver stagnation type IBS-D.Methods 70 cases of liver depression and spleen deficiency type diarrhea predominant IBS patients were selected and in accordance with the principle of random number were divided into observation group and control group, 35 cases in each group, control group was treated with shenlingbaizhupowder treatment, observation group was given shenlingbaizhu powder combined with flupentixol and melitracen tablets treatment,clinical curative effect between two groups was compared.Results The effective rate of the observation group was 91.43%, was higher than that of control group 77.14% (P<0.05).After treatment, the SDS score and SAS score of the two groups were improved (P<0.05), and the improvement effect of observation group was more obvious ( P <0.05 ) .Conclusion Shenlingbaizhu powder combined with flupentixol and melitracen tablets has good effect in treatment of liver depression and spleen deficiency type IBS-D, it is worthy of clinical application.%目的：探讨应用参苓白术散联合黛力新治疗脾虚肝郁型肠易激综合征腹泻型（ irritable bowel syndrome-diarrhea type ， IBS-D）患者的临床效果。方法选取收治的70例脾虚肝郁型IBS－D患者，并按照随机的原则将其分为观察组和对照组，其中对照组35例，给予该组患者单纯采用参苓白术散进行治疗，观察组35例，给予该组患者参苓白术散联合黛力新进行治疗，比较两组患者的临床治疗效果。结果观察组患者治疗的有效率为91.43％，高于对照组患者的77.14％（P＜0.05）。治疗结束后两组患者的SDS评分和SAS评分均有所改善（ P＜0.05），其中观察组患者改善效果较明显（ P＜0.05）。结论应用参苓白术散联合氟哌噻吨美利曲辛片对脾虚肝郁型IBS－D患者治疗的效果较为明显，值得临床推广应用。